Tricyclic Antidepressant Withdrawal Syndrome
- 1 September 1993
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 27 (9) , 1068-1072
- https://doi.org/10.1177/106002809302700912
Abstract
OBJECTIVE: To examine the evidence pointing to a withdrawal syndrome associated with the discontinuation of tricyclic antidepressants (TCAs). DATA SOURCES: MEDLINE searches were conducted. References used in relevant articles were screened for additional published information. STUDY SELECTION: Emphasis was placed on human trials and individual case reports. DATA SYNTHESIS: Symptoms of gastrointestinal and somatic distress, sleep disturbance, and movement disorders and mania have been temporally linked to withdrawal of TCAs. Cholinergic and adrenergic overdrive after TCA discontinuation have been suggested as the proposed mechanism for this syndrome. Reported symptoms may be psychosomatic or related to underlying mental illness. CONCLUSIONS: Clinicians should be aware that discontinuation of TCA therapy may produce a withdrawal syndrome in some patients.Keywords
This publication has 21 references indexed in Scilit:
- Symptoms of major depression: acute effect of withdrawing antidepressantsActa Psychiatrica Scandinavica, 1991
- Antidepressant Withdrawal SyndromesJournal of Clinical Psychopharmacology, 1983
- Hypomania after desipramine withdrawalAmerican Journal of Psychiatry, 1983
- Withdrawal symptoms after graduated cessation of imipramine in childrenAmerican Journal of Psychiatry, 1981
- Hypomania and mania after withdrawal of tricyclic antidepressantsAmerican Journal of Psychiatry, 1981
- Panic anxiety after abrupt discontinuation of amitriptylineAmerican Journal of Psychiatry, 1981
- Delirium after abrupt withdrawal from doxepin: case reportAmerican Journal of Psychiatry, 1980
- Withdrawal From Long-term High-Dose Desipramine TherapyArchives of General Psychiatry, 1978
- WITHDRAWAL SYMPTOMS FOLLOWING DISCONTINUATION OF IMIPRAMINE THERAPYAmerican Journal of Psychiatry, 1961
- Clinical Experience with Imipramine (G 22355) in the Treatment of DepressionCanadian Psychiatric Association Journal, 1959